Modulation of the G₂ Cell Cycle Checkpoint by Sesquiterpene Lactones Psilostachyins A and C Isolated from the Common Ragweed Ambrosia artemisiifolia

Abstract

A phenotypic cell-based assay for inhibitors of the G₂ DNA damage checkpoint was used to screen plant extracts from the US National Cancer Institute Natural Products Repository. It revealed activity in a methanol extract from the common ragweed Ambrosia artemisiifolia. Assay-guided fractionation led to the identification of the sesquiterpene lactones psilostachyins A and C as novel checkpoint inhibitors. Elimination of their α,β-unsaturated carbonyl group caused a loss of activity, suggesting that the compounds can bind covalently to target proteins through Michael addition. Psilostachyins A and C also blocked cells in mitosis and caused the formation of aberrant microtubule spindles. However, the compounds did not interfere with microtubule polymerization in vitro. The related sesquiterpene lactones psilostachyin B, paulitin and isopaulitin were also isolated from the same extract but showed no checkpoint inhibition. The identification of the target(s) of psilostachyins A and C may provide further insight into the signalling pathways involved in cell cycle arrest and mitotic progression.

Abbreviations

ATM:ataxia telangiectasia mutated

ATR:ATM- and Rad3-related

Chk:checkpoint kinase

CDC:cell division cycle

CDK:cyclin-dependent kinase

DBH:debromohymenialdisine

IGR:isogranulatimide

OZ:13-hydroxy-15-oxozoapatlin

Ambrosia artemisiifolia - cancer - cell cycle - checkpoint - G₂ phase - mitosis

References

• 1 Sancar A, Lindsey-Bolt L A, Unsal-Kacmaz K, Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints.  Annu Rev Biochem. 2004;  73 39-85
• 2 Kastan M B, Onyekwere O, Sidransky D, Vogelstein B, Craig R W. Participation of p53 protein in the cellular response to DNA damage.  Cancer Res. 1991;  51 6304-11
• 3 Kawabe T. G2 checkpoint abrogators as anticancer drugs.  Mol Cancer Ther. 2004;  3 513-9
• 4 Prudhomme M. Combining DNA damaging agents and checkpoint 1 inhibitors.  Curr Med Chem Anti-Canc Agents. 2004;  4 435-8
• 5 Anderson H J, Andersen R J, Roberge M. Inhibitors of the G2 DNA damage checkpoint and their potential for cancer therapy.  Prog Cell Cycle Res. 2003;  5 423-30
• 6 Sarkaria J N, Busby E C, Tibbetts R S, Roos P, Taya Y, Karnitz L M. et al . Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine.  Cancer Res. 1999;  59 4375-82
• 7 Zhou B BS, Chaturvedi P, Spring K, Scott S P, Johanson R A, Mishra R. et al . Caffeine abolishes the mammalian G2/M DNA damage checkpoint by inhibiting ataxia-telangiectasia-mutated kinase activity.  J Biol Chem. 2000;  275 10 342-8
• 8 Graves P R, Yu L, Schwarz J K, Gales J, Sausville E A, O'Connor P M. et al . The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01.  J Biol Chem. 2000;  275 5600-5
• 9 Yu Q, Rose J L, Zhang H, Takemura H, Kohn K W, Pommier Y. UCN-01 inhibits p53 up-regulation and abrogates gamma-radiation-induced G2-M checkpoint independently of p53 by targeting both of the checkpoint kinases, Chk2 and Chk1.  Cancer Res. 2002;  62 5743-8
• 10 Jiang X, Zhao B, Britton R, Lim L Y, Leong D, Sanghera J. et al . Inhibition of Chk1 by the G2 DNA damage checkpoint inhibitor isogranulatimide.  Mol Cancer Ther. 2004;  3 1221-7
• 11 Curman D, Cinel B, Williams D E, Rundle N, Block W D, Goodarzi A A. et al . Inhibition of the G2 DNA damage checkpoint and of protein kinases Chk1 and Chk2 by the marine sponge alkaloid debromohymenialdisine.  J Biol Chem. 2001;  276 17 914-9
• 12 Roberge M, Berlinck R GS, Xu L, Anderson H J, Lim L Y, Curman D. et al . High-throughput assay for G2 checkpoint inhibitors and identification of the structurally novel compound isogranulatimide.  Cancer Res. 1998;  58 5701-6
• 13 Budesínsky M, Saman D. Carbon-13 NMR spectra of sesquiterpene lactones. In: Webb GA, editor. Ann Rep NMR Spectrosc,. Vol. 30. San Diego; Academic Press; 1995.: p. 231-475.
• 14 Oberti J C, Silva G L, Sosa V E, Kulanthaivel P, Herz W. Ambrosanolides and secoambrosanolides from Ambrosia tenuifolia .  Phytochemistry. 1986;  25 1355-8
• 15 Rodriguez J G, Perales A. Molecular structure and absolute configuration of 2,3-didehydro-1,10-epoxypsilostachyin B (isopaulitin).  J Nat Prod. 1995;  58 564-9
• 16 Borges-del-Castillo J, Manresa-Ferrero M T, Rodriguez-Luis F, Vazquez-Bueno P, Joseph-Nathan P. Carbon-13 NMR study of psilostachyinolides from some Ambrosia species.  Org Magn Reson. 1981;  17 232-4
• 17 Mabry T J, Miller H E, Kagan H B, Renold W. The structure of psilostachyin, a new sesquiterpene dilactone from Ambroisia psilostachya .  Tetrahedron. 1966;  22 1139-46
• 18 Mabry T J, Kagan H B, Miller H E. Psilostachyin B, a new sesquiterpene dilactone from Ambrosia psilostachya DC.  Tetrahedron. 1966;  22 1943-8
• 19 Kagan H B, Miller H E, Renold W, Lakshmikantham M V, Tether L R, Herz W. et al . The structure of psilostachyin C, a new sesquiterpene dilactone from Ambrosia psilostachya DC.  J Org Chem. 1966;  31 1629-32
• 20 Lee I S, Shamon L A, Chai H B, Chagedera T E, Besterman J M, Farnsworth N R. et al . Cell-cycle specific cytotoxicity mediated by rearranged ent-kaurene diterpenoids isolated from Parinari curatellifolia .  Chem Biol Interact. 1996;  99 193-204
• 21 Rundle N T, Xu L, Andersen R J, Roberge M. G2 DNA damage checkpoint inhibition and antimitotic activity of 13-hydroxy-15-oxozoapatlin.  J Biol Chem. 2001;  276 48 231-6
• 22 Hadfield J A, Ducki S, Hirst N, McGown A T. Tubulin and microtubules as targets for anticancer drugs.  Prog Cell Cycle Res. 2003;  5 309-25
• 23 Bocca C, Gabriel L, Bozzo F, Miglietta A. A sesquiterpene lactone, costunolide, interacts with microtubule protein and inhibits the growth of MCF-7 cells.  Chem Biol Interact. 2004;  147 79-86
• 24 Miglietta A, Bozzo F, Gabriel L, Bocca C. Microtubule-interfering activity of parthenolide.  Chem Biol Interact. 2004;  149 165-73
• 25 Powell D N, DeFrank J S, Connell P, Eogan M, Preffer F, Dombkowski D. et al . Differential sensitivity of p53(-) and p53(+) cells to caffeine-induced radiosensitization and override of G2 delay.  Cancer Res. 1995;  55 1643-8
• 26 Russell K J, Wiens L W, Demers G W, Galloway D A, Plon S E, Groudine M. Abrogation of the G2 checkpoint results in differential radiosensitization of G1 checkpoint-deficient and G1 checkpoint-competent cells.  Cancer Res. 1995;  55 1639-42
• 27 Fan S, Smith ML 2 nd, DJR, Duba D, Zhan Q, Kohn K W. et al . Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline.  Cancer Res. 1995;  55 1649-54
• 28 Wang Q, Fan S, Eastman A, Worland P J, Sausville E A, O'Connor P M. UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53.  J Natl Cancer Inst. 1996;  88 956-65
• 29 Jiang X, Lim L Y, Daly J W, Li A H, Jacobson K A, Roberge M. Structure-activity relationships for G2 checkpoint inhibition by caffeine analogs.  Int J Oncol. 2000;  16 971-8
• 30 Braca A, Armenise A, Morelli I, Mendez J, Mi Q, Chai H B. et al . Structure of kaurane-type diterpenes from Parinari sprucei and their potential anticancer activity.  Planta Med. 2004;  70 540-50